Clinical trial

Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)

NCT04065347

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-11-21

PhaseN/A

Study timeline

Study start (actual)2019-11-21Date precision: day

Registry last updated2024-08-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDSunresolved

Adherence, Medicationunresolved

Interventions

Digital PillDEVICE

Sponsors & collaborators

University of Colorado, Denverlead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04065347 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.